Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"Heart--Preservation"”.
-
Heart preservation
In clinical transplantation today, the donor heart is preserved with cold ischemic storage that gives safe preservation for 4 hours. Non-ischemic perfusion preservation is able to preserve the donor heart for 24 hours in pre-clinical studies. The aim of this thesis is to investigate: 1. how …
-
Improving donor heart preservation: Pharmacologic conditioning and optimisation of donor heart preservation
Heart transplantation remains the gold standard treatment for end stage heart failure, however its use remains limited by a paucity of available donor hearts, and its efficacy by primary graft failure (PGF), the most common cause of mortality following heart transplantation. Research in the area of …
-
Donor Heart Preservation: Exploring Translational Strategies to Improve Donor Heart Preservation and Viability
… has been an ever-increasing demand for donor hearts due to an expanding end-stage heart failure population. Until 2014, donation after circulatory death (DCD) donors represented a non-utilised source of donor hearts. Our institute’s uptake of normothermic machine perfusion technology paved the …
-
Donor heart preservation for heart transplantation
Heart transplantation has enjoyed a spectacular success over the past 25 years. Prior to 1980 less than 350 operations were carried out with an overall one year survival of less than 60%. In 1995 more than 3,000 transplants were performed with a one year survival of 83%. However, growth and …
-
The use of pharmacological conditioning strategies to improve donor heart preservation in cardiac transplantation
… is the gold standard treatment for end-stage heart failure. Over the last 48 years, the profile of cardiac transplantation has evolved to include more higher-risk transplants, that is, longer ischaemic times, more ‘marginal’ organs and higher-risk recipients. However this is associated with an …
-
Pharmacological activation of pro-survival pathways as a strategy for improving donor heart preservation
… the development and use of specialised cardiac preservation solutions, the quality of the donor heart may still be compromised by its obligatory exposure to periods of ischaemia (both cold and warm) followed by reperfusion upon reintroduction of the recipient circulation. This is reflected in …
-
Passive Afterload Working Mode in Ex situ Heart Perfusion
Ex situ heart perfusion (ESHP) is an emerging technique that aims to combat the shortage of organs suitable for transplantation through the augmentation of both donor heart preservation and evaluation. The oldest and most common modality for ESHP is Langendorff mode (LM), where oxygenated perfusate …
-
Novel method for normothermic ex vivo preservation of donor heart using blood cardioplegia and conditioning /
Heart failure affects millions globally, with many patients on waiting lists for transplantation facing long delays and high mortality rates. The limited availability of suitable donor hearts, coupled with prolonged ischemic times during transport, poses significant challenges. However, the …
-
In-Silico design and verification of an extracorporeal normothermic cardiac perfusion system for use during heart transplantation procedures
Heart transplantation relies on effective donor organ preservation to ensure successful graft viability. Since the first human heart transplant in 1967 by Christiaan Barnard, organ preservation techniques have evolved from static cold storage with cardioplegic arrest to continuous blood perfusion, …
-
In-Silico design and verification of an extracorporeal normothermic cardiac perfusion system for use during heart transplantation procedures
Heart transplantation relies on effective donor organ preservation to ensure successful graft viability. Since the first human heart transplant in 1967 by Christiaan Barnard, organ preservation techniques have evolved from static cold storage with cardioplegic arrest to continuous blood perfusion, …
-
Enhancing Metabolism of Donor Hearts for Cardiac Transplantation
Congestive heart failure is a major health problem that affects millions of patients and represents a major cost to the health care system. Heart transplantation remains the most effective treatment for end-stage heart failure. However, transplantation can only be offered to a small fraction of …
-
Evaluation of an oxygen delivering mobile perfusion device for organ transport
… have been made to the clinical practice of donor heart preservation over the last 20 years. Using this protocol, viable storage of ex-vivo hearts is limited to no longer than 4 to 6 hours. In the present study, an oxygen delivering mobile perfusion device (ODMPD) was tested to determine if it …
-
Microvascular dysfunction during cardiac preservation.
Heart transplantation is, for certain types of cardiovascular disease, the only form of treatment resulting in patient survival. Its clinical application is, however, limited by the shortage of donor organs. This shortage is largely due to the inability to consistently preserve adequate myocardial …
-
The role of erythropoietin as a pharmacologic preconditioning agent in experimental cardiac allograft preservation
… the leading cause of early mortality following heart transplantation. It occurs as a consequence of the effects of donor brain death, ischaemia-reperfusion injury, and recipient factors. Research in the area of myocardial preservation is aimed at reducing the incidence of this feared …
-
Testing of RPMI-1640 as a nutrient medium for fresh semilunar valve storage
Thesis (M.S.)--Michigan State University. Department of Veterinary Surgery and Medicine, 1979
-
Optimization of techniques for cardiac preservation: Phosphorus-31 NMR spectroscopic and functional studies in isolated rat and pig hearts.
… in order to define better conditions for heart preservation (4 or 8 hrs). Myocardial energy metabolites (ATP, PCr and inorganic phosphate), intracellular pH and contractile function were followed using $\sp{31}$P NMR spectroscopy and left intra-ventricular balloon, respectively, during …
-
Myocardial ischemia-reperfusion and cardioprotection. A study with microdialysis in a porcine model.
… cardioplegic storage, or in the future during preservation of donor hearts by perfusion, monitoring of the donor heart before transplantation may be of benefit. We hypothesized, that myocardial microdialysate glycerol will reflect progressive damage. As the first step in pursuing this, in the …
Page 1 of 2